The table below shows Mirum Pharmaceuticals, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$55.83M
$10.32M
-$70.94M
-$120.14M
-$132.76M
-$89.08M
Capital expenditure
$954.00K
$993.00K
$109.00K
$278.00K
$24.00K
$225.00K
Investing cash flow
-$23.95M
-$90.13M
-$107.20M
$7.70M
$48.55M
$37.87M
Dividends paid
-
-
-
-
-
MIRM operating cash flow (10-K history)
Mirum Pharmaceuticals, Inc. reported operating cash flow of $55.83M for fiscal year 2025. That is up 440.7% from $10.32M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from -$39.36M (FY 2019) to $55.83M. Figures come from the company's audited annual reports as filed with the SEC.
